Navigation Links
CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
Date:1/31/2008

ATLANTA, Jan. 31 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that fourth quarter and year end 2007 financial results will be released on Thursday, February 21, 2008. The Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time, February 21, 2008, to discuss the results followed by a question and answer session hosted by Steven G. Anderson, president and chief executive officer of CryoLife, Inc.

To listen to the live teleconference please dial 201-689-8261 a few minutes prior to 10:00 a.m. A replay of the teleconference will be available February 21 through February 28, 2008 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The account number for the replay is 244 and the conference number is 271923.

The live webcast and replay can be accessed by going to the Investor Relations section of the CryoLife Web site at http://www.cryolife.com and selecting the heading Webcasts & Presentations.

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Communit
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
2. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
3. CryoLife Announces Record Preservation Services and Product Revenues for 2007
4. CryoLife to Present at OneMedPlace Finance Forum
5. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
6. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
7. CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million
8. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
9. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
10. CryoLife Names Philip Theodore as Vice President, General Counsel
11. GeoPharma Announces Third Quarter Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... 34-year veteran of the high-technology industry, ...s development and intellectual property management...ace. The company also plans to invest in promisin...or. , Monterey, CA (PRWEB...r veteran of the high-technology industry, has for...
(Date:11/30/2009)...ternational team of applied scientists from Harvar...rated compact, multibeam, and multi-wavelength las...ectrum (infrared). By contrast, typical lasers emi.... The innovative multibeam lasers have potential u...ing pollution monitoring, optical wireless, and in...
(Date:11/30/2009)...wswire/ -- Acuo Technologies, developers of high-p... migration tools and services, today announced con...ew Vendor Neutral Archive (VNA), providing the fou... of hospitals, clinics and affiliates. ,, The a...s DICOM Services Grid(TM) Software. The Acuo VNA ...
(Date:11/30/2009)...ire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) a...hat the company will be presenting at the 21st Ann...9 at 12:30 pm local time at The New York Palace, N...company,s business strategy, research and developm...he live audio only presentation can be accessed vi...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...Jersey, December 5, Rosetta Genomics, Ltd. (NASDAQ...pany leveraging microRNAs as biomarkers,reported t...arter ended,September 30, 2008 and business highli...e third quarter of 2008 of $705,000.,These revenue...rkway Clinical,Laboratories at the end of July thr...
...c.,(Nasdaq: MDVN ) today announced that David Hu...ill be a featured speaker on two panels at the RBC...rsday, December 11, in New York: , -- "Wagin...tern Time, -- "The Challenge of Alzheimer,s Dis... A live audio webcast of each panel will be ...
... 4 Octapharma,Chairman Wolfgang Marguerre today a...o lead Octapharma,s plasma operations in the Unite...counsel since 2002 and will now serve as,President...ivate plasma products company in the world, Octaph...nta company that operates 12,plasma centers in the...
Other Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2
(Date:11/30/2009)...roteins are crucial for infection. Each binds a sp...ch stimulates the host cell to take up the pathoge...erent function, for example the regulation of cell...e now been published in the current issue of the "...is one of the sources for Listeria infections le...
(Date:11/30/2009)...stress of seeing your extended family over the hol...ch report in the December 2009 print issue of the ...io.org ) shows that you might be right. Here,s the... to entirely new treatments that help keep autoimm...er control. That,s because researchers from the Un...
(Date:11/26/2009)...me of the Ocean,s most distinctive residents. ,Eve...ge head shape, says Michelle McComb from Florida ...ark,s vision. ,Perhaps their visual field has been... giving the sharks excellent stereovision and dept...were two schools of thought on this theory. In 194...
Breaking Biology News(10 mins):It takes 2 to infect 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Wide heads give hammerheads exceptional stereo view 2The Chopra Center Press Set to Release New Book this June 25 49801 1The Chopra Center Press Set to Release New Book this June 25 49801 2The Chopra Center Press Set to Release New Book this June 25 49801 3A Canada wide technology platform for mapping the human interactome 8974 1A Canada wide technology platform for mapping the human interactome 8974 2Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 1Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 2Video 3A Gabrielle Reece Shows Natural is Beautiful in New PureVia 28TM 29 Campaign 49795 3
...Researchers at New York University,s Courant Insti... algorithm that enhances the ability to detect a c...p the set of tumor-suppressor genes involved in lu...,s gene-chips that can scan hundreds of patients, ...he findings will appear in the July issue of the A...
...Knee cartilage injuries can be effectively repaire...t stop the regeneration process concludes research... The study, "Maturation of tissue engineered carti... knees", published in the July 2006 (Volume 12, Nu...that engineered cartilage tissue can grow and matu...
...Bacteria like Salmonella have a complicated immune...ign DNA trying to invade their cell membrane, acco...he June 8 issue of Science Express. The research, ...l Cancer Center in San Diego, could have major imp...se-causing bacteria. The findings may also impact ...
Other Biology News:NYU algorithm enhances ability to detect cancer genes 2NYU algorithm enhances ability to detect cancer genes 3Bacteria have their own immune system protecting against outside DNA 2
Sheep Anti-Human Vesicle Associated Membrane Protein (VAMP 1/2) Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited
Feline IFN-alpha, Unconjugated from R&D Systems
...A Development kit contains the basic components re...easure natural and recombinant canine Monocyte Che...tes and serum.1 Each kit contains sufficient mater...l plates, provided that the following conditions a...
Biology Products: